| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/07/2005 | CN1218038C Horse infectious anemia donkey embryo skin cell weak-toxic vaccine strain and culture method thereof |
| 09/07/2005 | CN1217956C Soluble single-chain T-cell receptor proteins |
| 09/07/2005 | CN1217954C Rabbit hemorrhagic disease virus (RHDV) recombinant capsids and proteins, diagnostic kits and vaccines containing said RHDV recombinant capsids and proteins |
| 09/07/2005 | CN1217698C Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents |
| 09/07/2005 | CN1217697C Peptide antagonists of zonulin and methods for use of same |
| 09/06/2005 | US6939959 Efficient protein expression system |
| 09/06/2005 | US6939957 corresponding proteins with recombinant plasmids bearing the nucleotide sequences in Escherichia coli; nucleocapsid (NP) protein and phosphoprotein (P) |
| 09/06/2005 | US6939862 Method for transferring nucleic acid into striated muscles |
| 09/06/2005 | US6939697 Isolating and purifying therapeutic polypeptide using undulating solid support comprising polyethersulphone |
| 09/06/2005 | US6939689 site-directed mutagenesis; annealing |
| 09/06/2005 | US6939677 useful for detection, diagnosis, and treatment of breast cancer; Human milk fat globule ( HMFG) |
| 09/06/2005 | US6939549 To reduce the severity or prevent infection by ehrlichial parasites of the species Anaplasma marginale |
| 09/06/2005 | US6939548 Clostridium (C.) vaccination; fusion proteins; antibiotic resistance |
| 09/06/2005 | US6939546 Model for testing immunogenicity of peptides |
| 09/06/2005 | US6939543 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 09/06/2005 | US6939533 Non-invasive localization of a light-emitting conjugate in a mammal |
| 09/06/2005 | CA2105652C Reducing wound scarring with antibodies to growth factors |
| 09/01/2005 | WO2005080985A2 Methods and compositions for detecting and treating autoimmune diseases |
| 09/01/2005 | WO2005080984A1 Modulators of angiogenesis and tumorigenesis |
| 09/01/2005 | WO2005080972A1 Use of tweak modulators and inhibitors for the treatment of neurological conditions |
| 09/01/2005 | WO2005080939A2 Method and device for detecting feline immunodeficiency virus |
| 09/01/2005 | WO2005080597A1 Method for diagnosing colorectal cancers |
| 09/01/2005 | WO2005080586A1 Fusion proteins containing recombinant cytotoxic rnases |
| 09/01/2005 | WO2005080567A1 Substituted, non-coding nucleic acid molecule used for the therapeutic and prophylactic immune stimulation in humans and higher animals |
| 09/01/2005 | WO2005080435A1 Monoclonal antibody and use thereof |
| 09/01/2005 | WO2005080431A2 Monoclonal antibodies that specifically bind to folate receptor alpha |
| 09/01/2005 | WO2005080427A1 Galanin receptors and brain injury |
| 09/01/2005 | WO2005080419A1 Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof |
| 09/01/2005 | WO2005080418A2 Multimerised hiv fusion inhibitors |
| 09/01/2005 | WO2005080416A1 Feline calicivirus vaccines |
| 09/01/2005 | WO2005079848A2 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders |
| 09/01/2005 | WO2005079843A1 Novel liposome |
| 09/01/2005 | WO2005079842A1 Immunological adjuvant |
| 09/01/2005 | WO2005079841A2 Gm1 binding deficient exotoxins for use as immunoadjuvants |
| 09/01/2005 | WO2005079840A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 09/01/2005 | WO2005079837A1 Methods of modulating il-23 activity; related reagents |
| 09/01/2005 | WO2005079833A1 T cell immune response inhibitor |
| 09/01/2005 | WO2005079766A2 Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds |
| 09/01/2005 | WO2005079755A2 Interleukin-13 antagonist powders, spray-dried particles, and methods |
| 09/01/2005 | WO2005079581A1 Intratumoral delivery of dendritic cells |
| 09/01/2005 | WO2005079508A2 Method and composition for angiogenesis inhibition |
| 09/01/2005 | WO2005079506A2 Systemic immune activation method using nucleic acid-lipid complexes |
| 09/01/2005 | WO2005079490A2 Methods of therapy and diagnosis using targeting of cells that express steap2 polypeptides |
| 09/01/2005 | WO2005079489A2 Method of treating cancer and identifying novel anti-ancer compounds |
| 09/01/2005 | WO2005079479A2 Super-humanized antibodies against respiratory syncytial virus |
| 09/01/2005 | WO2005079423A2 Chemically programmable immunity |
| 09/01/2005 | WO2005079398A2 Drug conjugates |
| 09/01/2005 | WO2005079315A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/01/2005 | WO2005079271A2 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer |
| 09/01/2005 | WO2005079267A2 Methods for protein production |
| 09/01/2005 | WO2005079232A2 A METHOD FOR THE PRODUCTION OF AN ERYTHROPOIETIN ANALOG-HUMAN IgG FUSION PROTEINS IN TRANSGENIC MAMMAL MILK |
| 09/01/2005 | WO2005065711A3 Mammalian receptor proteins; related reagents and methods |
| 09/01/2005 | WO2005059136A3 Dna-sequence and recombinant production of group 4 major allergens from cereals |
| 09/01/2005 | WO2005049080B1 Vaccine composition admixed with an alkylphosphatidylcholine |
| 09/01/2005 | WO2005047476A3 Inhibition of retroviral replication through modulation of the host cell ubiquitylation |
| 09/01/2005 | WO2005034839A3 Porifera-based therapeutic compositions for treating and preventing skin diseases |
| 09/01/2005 | WO2005031001A3 Novel therapeutic targets in cancer |
| 09/01/2005 | WO2005002619A3 Immunogenic compositions for chlamydia trachomatis |
| 09/01/2005 | WO2004076639A8 Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus |
| 09/01/2005 | WO2004073656A9 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/01/2005 | WO2004067718A3 Necrosis-deficient mutants of tuberculosis bacteria |
| 09/01/2005 | WO2004060911A3 Combination therapy with co-stimulatory factors |
| 09/01/2005 | WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases |
| 09/01/2005 | WO2004024067A3 Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection |
| 09/01/2005 | WO2003089574A3 Synthetic glyco-lipo-peptides as vaccines |
| 09/01/2005 | WO2003013426A3 Multivalent synthetic vaccine for cancer |
| 09/01/2005 | US20050192514 Audiological treatment system and methods of using the same |
| 09/01/2005 | US20050192429 Immunoglobulin mixture specific to endothelial growth factor for use as tools in treatment and prevention of cell prolifreative disorders; antitumor agents |
| 09/01/2005 | US20050192237 Antisense antibacterial cell division composition and method |
| 09/01/2005 | US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections |
| 09/01/2005 | US20050191743 Using biological scaffold to propagate lymphocytic cells |
| 09/01/2005 | US20050191712 immunoassay of acidic repeat protein/immunogens; solid phase synthesis; kits for diagnosis of syphilis |
| 09/01/2005 | US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
| 09/01/2005 | US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |
| 09/01/2005 | US20050191688 Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| 09/01/2005 | US20050191650 Used to reduce body temperature, suppress appetite, and therapy or prophylaxis of congestive heart failure and various stress-related disorders |
| 09/01/2005 | US20050191649 Identifying mutation in oligoadenylate synthetase gene (OAS1); identifying modulators for prevention and treatment of cell proliferative, nervous system and diabetic disorders |
| 09/01/2005 | US20050191621 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 09/01/2005 | US20050191367 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 09/01/2005 | US20050191358 Microparticles with adsorbed polynucleotide-containing species |
| 09/01/2005 | US20050191342 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 09/01/2005 | US20050191321 Combination of local botulinum toxin and oral triptan drug administration; preventing overuse; reducing pain sensory output |
| 09/01/2005 | US20050191320 Local delivery of botulinum toxin to target area; headaches, acute and chronic pain |
| 09/01/2005 | US20050191319 Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| 09/01/2005 | US20050191318 Recombinant bacterial host; vector encoding egg or sperm species specific polypeptide; inducing sterility; baits for controlling animal and rodent populations |
| 09/01/2005 | US20050191317 Modified virus like particles; antiobesity agents |
| 09/01/2005 | US20050191316 Neisseria genomic sequences and methods of their use |
| 09/01/2005 | US20050191315 Identification of epitopes on staphylococcal enterotoxins |
| 09/01/2005 | US20050191314 vaccine comprosing a mixture of A beta oligomers capable of generating an immune response; prophylaxis and treatment of Alzheimer's disease |
| 09/01/2005 | US20050191313 Vaccine and immunotherapy for solid nonlymphoid tumor and related immune dysregulation |
| 09/01/2005 | US20050191312 Diagnosis by detecting overexpression; active or passive immunization; antibodies, transgenic animals, hybridoma |
| 09/01/2005 | US20050191311 Nucleic acids and corresponding proteins entitled 109P1D4 useful in treatment and detection of cancer |
| 09/01/2005 | US20050191310 Novel compositions of saponin adjuvants and excipients |
| 09/01/2005 | US20050191309 Induction of antigen specific immunologic tolerance |
| 09/01/2005 | US20050191308 Adjuvant combinations for immunization composition and vaccines |
| 09/01/2005 | US20050191306 Cancerous disease modifying antibodies |
| 09/01/2005 | US20050191305 Cancerous disease modifying antibodies |
| 09/01/2005 | US20050191304 Employing Zvegf3 antagonists |
| 09/01/2005 | US20050191302 Administering an inducer (sulfasalazine) of hepatic stellate cell apoptosis; selective delivery; fibrosis; inhibiting interaction of a tissue inhibitor of a matrix metalloprotease (TIMP) with a matrix metalloprotease |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |